Published in Am J Gastroenterol on March 10, 2009
Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology (2015) 1.69
Diagnosis and management of bacterial infections in decompensated cirrhosis. World J Hepatol (2013) 0.99
Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol (2014) 0.95
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol (2015) 0.93
Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity? PLoS One (2010) 0.89
Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol (2016) 0.83
Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis. Clin Mol Hepatol (2013) 0.79
Ascites and spontaneous bacterial peritonitis: recommendations from two United States centers. Saudi J Gastroenterol (2014) 0.76
Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol (2016) 0.75
[Complications of end-stage liver disease]. Can Fam Physician (2016) 0.75
Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients. World J Hepatol (2016) 0.75
Complications of end-stage liver disease. Can Fam Physician (2016) 0.75
Fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis. Am J Gastroenterol (2010) 0.75
Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review. BMJ Open Gastroenterol (2017) 0.75
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med (2003) 5.97
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology (2008) 3.82
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology (2005) 2.04
Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol (2009) 1.97
MELD fails to measure quality of life in liver transplant candidates. Liver Transpl (2005) 1.79
Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model. Liver Transpl (2010) 1.69
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology (2005) 1.66
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc (2010) 1.65
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg (2008) 1.65
Chronic viral hepatitis and hepatocellular carcinoma. World J Surg (2007) 1.62
Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review. Liver Transpl (2010) 1.61
Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. J Hepatol (2007) 1.60
Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants. Clin Infect Dis (2008) 1.47
Acinetobacter infection: what was the true impact during the Vietnam conflict? Clin Infect Dis (2006) 1.42
Impact of coffee on liver diseases: a systematic review. Liver Int (2013) 1.42
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.37
An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol (2011) 1.26
Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis (2010) 1.14
CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 1.13
Management of patients with cirrhosis in Southern California: results of a practitioner survey. J Clin Gastroenterol (2006) 1.05
Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transpl (2009) 1.05
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
The emerging importance of chronic hepatitis C infection in Asian Americans. Am J Gastroenterol (2006) 0.98
The impact of obesity on patient survival in liver transplant recipients: a meta-analysis. Liver Int (2014) 0.96
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg (2011) 0.95
Impact of a bladder cancer diagnosis on smoking behavior. J Clin Oncol (2012) 0.92
Employment and quality of life in liver transplant recipients. Liver Transpl (2007) 0.91
Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc (2009) 0.91
Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model. Hepatology (2007) 0.86
The MELD score in advanced liver disease: association with clinical portal hypertension and mortality. Exp Clin Transplant (2006) 0.85
Favorable outcomes of autoimmune hepatitis in a community clinic setting. J Gastroenterol Hepatol (2008) 0.85
Complete tumor encapsulation on magnetic resonance imaging: a potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma. Liver Transpl (2013) 0.83
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. Liver Transpl (2007) 0.81
Acute urinary retention caused by a large peritoneal inclusion cyst: a case report. J Reprod Med (2006) 0.81
Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population? J Gastroenterol Hepatol (2011) 0.80
Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Exp Clin Transplant (2016) 0.80
Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir. Liver Int (2013) 0.79
Clinical roundtable monograph. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma. Clin Adv Hematol Oncol (2010) 0.78
MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. AJR Am J Roentgenol (2012) 0.78
Quality of end-of-life care in low-income, uninsured men dying of prostate cancer. Cancer (2010) 0.78
Pretransplant variables associated with quality of life in liver transplant recipients. Liver Int (2008) 0.77
Medical therapies to extend survival in hepatocellular carcinoma. Clin Adv Hematol Oncol (2008) 0.77
Images in reproductive medicine. Disseminated leiomyomatosis peritonei. Fertil Steril (2005) 0.77
A proposed, evidence-based approach to the treatment of chronic Hepatitis B. J Clin Gastroenterol (2011) 0.77
Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation. J Gastroenterol Hepatol (2014) 0.77
Timing of Antiviral Therapy in Candidates for Liver Transplant for Hepatitis C and Hepatocellular Carcinoma. Exp Clin Transplant (2015) 0.76
Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Exp Clin Transplant (2016) 0.76
Is the search for a single comprehensive staging system for hepatocellular carcinoma an elusive one? J Clin Gastroenterol (2009) 0.75
Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2010) 0.75